Target intelligence / Profile preview

Thromboxane A2 receptor (TPα) (TPα)

Target
TPα
Molecular classification
G protein-coupled receptor, Receptor, Prostanoid receptor
01

Overview

Thromboxane A2 receptor TPα is a G protein-coupled receptor encoded by the TBXA2R gene located on chromosome 19p13.3[1][5]. It is the α isoform resulting from alternative splicing of TBXA2R, differing from TPβ by a shorter cytoplasmic tail (343 vs. 407 amino acids)[1][5]. TPα is abundantly expressed in platelets, vascular smooth muscle, and endothelial cells, and is pivotal in hemostasis, platelet activation, and aggregation[1][3][5]. Upon activation by its primary ligand, thromboxane A2 (TXA2)—a short-lived eicosanoid produced by activated platelets—TPα initiates intracellular signaling via heterotrimeric G proteins (mainly Gq/G11), leading to platelet shape change, degranulation, aggregation, and vasoconstriction[1][3][5]. TPα is considered a prothrombotic receptor, with overactivity implicated in cardiovascular and cerebrovascular diseases, and its inhibition is a therapeutic strategy in cardiovascular disease[4][5]. Besides TXA2, TPα can also be activated by other eicosanoids (PGH2, PGF2α)[5]. Genetic and pharmacological studies in animal models demonstrate that TPα is essential for stable clot formation, and its blockade or deficiency results in impaired hemostasis and increased bleeding tendency[5]. In the vasculature, sustained TPα activation contributes to endothelial dysfunction, hypertension, and microvascular rarefaction[4]. TPα is thus a validated pharmacological target for antiplatelet and antithrombotic therapies, but its inhibition must be carefully balanced against bleeding risk.

Other names
TXA2 receptor αTP receptor αProstanoid TP receptor αThromboxane receptor αTXA2RTP-αTXA2Rα
02

Mechanism of action

Inhibition of TPα signaling reduces platelet activation, aggregation, and vasoconstriction; Antagonists competitively or non-competitively block receptor activation; Aspirin inhibits upstream TXA2 synthesis by irreversibly inhibiting cyclooxygenase-1 (COX-1)[2]; TPα primarily couples to Gq/G11, activating phospholipase C, increasing intracellular calcium, and inducing cell contraction; May also couple to G12/13 and Gs in some cell types[5][7].

03

Biological functions

Signal transductionPlatelet activationPlatelet aggregationVascular smooth muscle contractionVasoconstrictionAngiogenesis modulationCell migrationCell adhesion
04

Disease associations

Cardiovascular diseaseHypertensionAtherosclerosisStrokeMyocardial infarctionEndothelial dysfunctionInflammationOther
05

Safety considerations

TPα is critical for hemostasis; inhibition may increase bleeding risk—especially with antiplatelet drugspotential for off-target effects in non-platelet cells (e.g., vasculature, kidney, lung)possible interference with beneficial prostacyclin (PGI2)-mediated effects[5]
06

Interacting drugs

Antagonists (e.g., terutroban, ifetroban, seratrodast, ramatroban)

2 more in the full profile.

07

Biomarkers

11-dehydrothromboxane B2 (urinary metabolite reflecting systemic TXA2 production)[2]TPα gene/protein expression in platelets and vasculatureCirculating TXA2 levels (inferred, rarely measured directly due to short half-life)

Beyond the preview

Go deeper on Thromboxane A2 receptor (TPα) (TPα).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thromboxane A2 receptor (TPα) (TPα).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call